Πλοήγηση ανά Θέμα "URINARY-BLADDER"
Αποτελέσματα 1-4 από 4
-
In vitro biocompatibility between mitomycin-C (MMC) and bacillus Calmette-Guerin (BCG)
(2006)Background: Mitomycin-C (MMC) and bacillus Calmette-Guerin (BCG) intravesical instillations are widely and effectively used as adjuvant treatment for superficial bladder cancer. In an attempt to improve the efficacy of ... -
Mismatch repair hMSH2, hMLH1, hMSH6 and hPMS2 mRNA expression profiles in precancerous and cancerous urothelium
(2013)Changes in the expression of the mismatch repair (MMR) genes hMSH2, hMLH1, hMSH6 and hPMS2 reflect dysfunction of the DNA repair system that may allow the malignant transformation of tissue cells. The aim of the present ... -
Molecular Pathogenesis of Non Muscle-Invasive Bladder Cancer: Implications for Novel Targeted Therapies
(2011)Approximately 70% to 80% of patients with urothelial carcinomas of the bladder are initially diagnosed with non-muscle invasive disease. Superficial, non-muscle invasive bladder cancers (NMIBCs) are managed with cystoscopic ... -
A weekly hypofractionated radiotherapeutic schedule for bladder carcinoma in elderly patients: local response, acute and late toxicity, dosimetric parameters and pain relief
(2013)Purpose: To investigate the early and late toxicity of a hypofractionated radiotherapy (RT) schedule to treat muscle-invasive bladder cancer in relation to radiation parameters according to the organs at risk. Methods: ...